Artificial Intelligence Conference 2026

Background The histopathology is to be the essential basis for cancer diagnosis, classification, and staging. In conventional histopathology, pathologists visually review stained tissue biopsy samples via microscopes. This process is time-consuming. By changing to digital pathology, high-resolution whole slide images are generated by scanning glass slides. Artificial intelligence (AI) models have incredible speed and accuracy in analyzing microscopic structures. Pathologists apply AI and machine learning (ML) tools to assess challenging tissue images so as improve diagnostic efficiency and accuracy ,cut down turnover time, and assist with an early detection and treatment regimen. Micro-metastasis detection is the power of computer vision techniques to locate migrating cancer cells which are difficult for the human eye to see. Objective The poster presentation aims and focus on early lesion detection, tumor categorization, grading, and cancer staging support, this paper aims to focus on the developing importance of AI and ML techniques in histopathology diagnosis and cancer staging. Methods The current applications of AI-driven digital pathology frameworks were reviewed, with an emphasis on machine learning and deep learning techniques for whole slide image analysis. Key applications such as biomarker evaluation, cancer grading, tumor segmentation, automated lesion recognition, and predictive pathology were assessed. Results AI-assisted histopathology has shown promising ability in detecting tumor locations, spotting subtle morphological patterns, and aiding with standardized evaluation of cancer characteristics. Convolutional neural networks in particular, are deep learning models that have been used in fields like metastatic lesion identification, breast cancer assessment [1], colorectal cancer analysis, prostate cancer grading [2].These technologies offer chances to reduce diagnostic fluctuations, enhance efficiency in workflow, improve early detection [3] . Conclusion Artificial Intelligence and Machine Learning represent transformative tools in modern pathology by augmenting the expertise of pathologists and supporting accuracy, early lesion detection, efficient, and personalized early cancer treatment that decreases the mortality rate. Successful clinical integration requires robust validation, diverse datasets, ethical considerations, and continued collaboration between pathologists, clinicians, and AI developers. Keywords: Artificial Intelligence; Machine Learning; Digital Pathology; Histopathology; Deep Learning; Cancer Staging; Precision .

Dr. Indumathi is the Professor and Head of the Department of Pathology and Assistant Dean of Faculty Affairs at Texila American University College of Medicine. With over a decade of experience in medical education, academic leadership, research, and diagnostic pathology, she has played a key role in developing and strengthening integrated pathology programs and USMLE-based medical curricula across teaching institutions and universities.

A dedicated educator and researcher, Dr. Indu has contributed extensively to medical science through publications in National & International Indexed journals and presentations at international conferences. She served as Secretary and Chairperson of Scientific Sessions at the 6th International Conference on Artificial Intelligence in Healthcare at Texila American University, reflecting her interest in advancing innovation in healthcare education and practice. Her other areas of expertise include Digital Pathology, Diagnostic Pathology- Histopathology, Cytopathology, Hematology, Flow Cytometry, IHC, and clinical practice as a Diabetologist.

Dr. Indu's accomplishments have been recognized with several prestigious awards, including the Pushkar Award for University Rank in Postgraduate Studies, the Teaching Excellence Award from Texila American University, the Achievement Award from the Ministry of Defense Earth BEML, and the Dedicated Doctor Award from the Medical Association.